Increased Angiogenesis and Improved Left Ventricular Function After Transplantation of Myoblasts Lacking the MyoD Gene into Infarcted Myocardium

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2012 Aug 1

PMID 22848585

Citations 7

Authors

Yasuhiro Nakamura

Yoko Asakura

Bryan A Piras

Hiroyuki Hirai

Christopher T Tastad

Mayank Verma

Amanda J Christ

Jianyi Zhang

Takanori Yamazaki

Minoru Yoshiyama

Atsushi Asakura

Affiliations

Soon will be listed here.

Abstract

Skeletal myoblast transplantation has therapeutic potential for repairing damaged heart. However, the optimal conditions for this transplantation are still unclear. Recently, we demonstrated that satellite cell-derived myoblasts lacking the MyoD gene (MyoD(-/-)), a master transcription factor for skeletal muscle myogenesis, display increased survival and engraftment compared to wild-type controls following transplantation into murine skeletal muscle. In this study, we compare cell survival between wild-type and MyoD(-/-) myoblasts after transplantation into infarcted heart. We demonstrate that MyoD(-/-) myoblasts display greater resistance to hypoxia, engraft with higher efficacy, and show a larger improvement in ejection fraction than wild-type controls. Following transplantation, the majority of MyoD(-/-) and wild-type myoblasts form skeletal muscle fibers while cardiomyocytes do not. Importantly, the transplantation of MyoD(-/-) myoblasts induces a high degree of angiogenesis in the area of injury. DNA microarray data demonstrate that paracrine angiogenic factors, such as stromal cell-derived factor-1 (SDF-1) and placental growth factor (PlGF), are up-regulated in MyoD(-/-) myoblasts. In addition, over-expression and gene knockdown experiments demonstrate that MyoD negatively regulates gene expression of these angiogenic factors. These results indicate that MyoD(-/-) myoblasts impart beneficial effects after transplantation into an infarcted heart, potentially due to the secretion of paracrine angiogenic factors and enhanced angiogenesis in the area of injury. Therefore, our data provide evidence that a genetically engineered myoblast cell type with suppressed MyoD function is useful for therapeutic stem cell transplantation.

Citing Articles

Vascular and Perivascular Role in the Regulation of Angiogenesis: Impact on Arteriovenous Fistula Maturation.

Xia F, Rai V, Agrawal D Arch Intern Med Res. 2024; 7(4):284-296.

PMID: 39698202 PMC: 11654682. DOI: 10.26502/aimr.0185.

Fibrin-Enriched Cardiac Extracellular Matrix Hydrogel Promotes Angiogenesis.

Shaik R, Xu J, Wang Y, Hong Y, Zhang G ACS Biomater Sci Eng. 2023; 9(2):877-888.

PMID: 36630688 PMC: 10064974. DOI: 10.1021/acsbiomaterials.2c01148.

Electrospun Fiber-Coated Human Amniotic Membrane: A Potential Angioinductive Scaffold for Ischemic Tissue Repair.

Hasmad H, Idrus R, Sulaiman N, Lokanathan Y Int J Mol Sci. 2022; 23(3).

PMID: 35163664 PMC: 8836161. DOI: 10.3390/ijms23031743.

Biological and Pro-Angiogenic Properties of Genetically Modified Human Primary Myoblasts Overexpressing Placental Growth Factor in In Vitro and In Vivo Studies.

Zimna A, Wiernicki B, Kolanowski T, Rozwadowska N, Malcher A, Labedz W Arch Immunol Ther Exp (Warsz). 2017; 66(2):145-159.

PMID: 28951939 PMC: 5851700. DOI: 10.1007/s00005-017-0486-2.

Tracking the Fate of Muscle-derived Stem Cells: an Insight into the Distribution and Mode of Action.

Park H, Choi G, Hahn S, Yoo Y, Jung I, Lee T Vasc Specialist Int. 2015; 30(1):11-8.

PMID: 26217610 PMC: 4480300. DOI: 10.5758/vsi.2014.30.1.11.

References

Watanabe S, Hirai H, Asakura Y, Tastad C, Verma M, Keller C . MyoD gene suppression by Oct4 is required for reprogramming in myoblasts to produce induced pluripotent stem cells. Stem Cells. 2011; 29(3):505-16. PMC: 3734538. DOI: 10.1002/stem.598. View

Hagege A, Marolleau J, Vilquin J, Alheritiere A, Peyrard S, Duboc D . Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients. Circulation. 2006; 114(1 Suppl):I108-13. DOI: 10.1161/CIRCULATIONAHA.105.000521. View

Pelacho B, Nakamura Y, Zhang J, Ross J, Heremans Y, Nelson-Holte M . Multipotent adult progenitor cell transplantation increases vascularity and improves left ventricular function after myocardial infarction. J Tissue Eng Regen Med. 2007; 1(1):51-9. DOI: 10.1002/term.7. View

Shintani Y, Fukushima S, Varela-Carver A, Lee J, Coppen S, Takahashi K . Donor cell-type specific paracrine effects of cell transplantation for post-infarction heart failure. J Mol Cell Cardiol. 2009; 47(2):288-95. DOI: 10.1016/j.yjmcc.2009.05.009. View

Uemura R, Xu M, Ahmad N, Ashraf M . Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res. 2006; 98(11):1414-21. DOI: 10.1161/01.RES.0000225952.61196.39. View

Asakura A, Komaki M, Rudnicki M . Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. Differentiation. 2002; 68(4-5):245-53. DOI: 10.1046/j.1432-0436.2001.680412.x. View

Toma C, Pittenger M, Cahill K, Byrne B, Kessler P . Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. 2002; 105(1):93-8. DOI: 10.1161/hc0102.101442. View

Kolossov E, Bostani T, Roell W, Breitbach M, Pillekamp F, Nygren J . Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med. 2006; 203(10):2315-27. PMC: 2118112. DOI: 10.1084/jem.20061469. View

Williams A, Valdez G, Moresi V, Qi X, McAnally J, Elliott J . MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science. 2009; 326(5959):1549-54. PMC: 2796560. DOI: 10.1126/science.1181046. View

10.

Payne T, Oshima H, Okada M, Momoi N, Tobita K, Keller B . A relationship between vascular endothelial growth factor, angiogenesis, and cardiac repair after muscle stem cell transplantation into ischemic hearts. J Am Coll Cardiol. 2007; 50(17):1677-84. DOI: 10.1016/j.jacc.2007.04.100. View

11.

Verma M, Asakura Y, Hirai H, Watanabe S, Tastad C, Fong G . Flt-1 haploinsufficiency ameliorates muscular dystrophy phenotype by developmentally increased vasculature in mdx mice. Hum Mol Genet. 2010; 19(21):4145-59. PMC: 2951865. DOI: 10.1093/hmg/ddq334. View

12.

Pyo J, Nah J, Kim H, Chang J, Song Y, Yang D . Protection of cardiomyocytes from ischemic/hypoxic cell death via Drbp1 and pMe2GlyDH in cardio-specific ARC transgenic mice. J Biol Chem. 2008; 283(45):30707-14. PMC: 2662156. DOI: 10.1074/jbc.M804209200. View

13.

Molkentin J, Olson E . Defining the regulatory networks for muscle development. Curr Opin Genet Dev. 1996; 6(4):445-53. DOI: 10.1016/s0959-437x(96)80066-9. View

14.

Menasche P, Hagege A, Vilquin J, Desnos M, Abergel E, Pouzet B . Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol. 2003; 41(7):1078-83. DOI: 10.1016/s0735-1097(03)00092-5. View

15.

Sondergaard C, Hess D, Maxwell D, Weinheimer C, Rosova I, Creer M . Human cord blood progenitors with high aldehyde dehydrogenase activity improve vascular density in a model of acute myocardial infarction. J Transl Med. 2010; 8:24. PMC: 2846892. DOI: 10.1186/1479-5876-8-24. View

16.

Nakamura Y, Yoshiyama M, Omura T, Yoshida K, Kim S, Takeuchi K . Transmitral inflow pattern assessed by Doppler echocardiography in angiotensin II type 1A receptor knockout mice with myocardial infarction. Circ J. 2002; 66(2):192-6. DOI: 10.1253/circj.66.192. View

17.

Jain M, DerSimonian H, Brenner D, Ngoy S, Teller P, Edge A . Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Circulation. 2001; 103(14):1920-7. DOI: 10.1161/01.cir.103.14.1920. View

18.

Askari A, Unzek S, Popovic Z, Goldman C, Forudi F, Kiedrowski M . Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet. 2003; 362(9385):697-703. DOI: 10.1016/S0140-6736(03)14232-8. View

19.

Masuda H, Asahara T . Post-natal endothelial progenitor cells for neovascularization in tissue regeneration. Cardiovasc Res. 2003; 58(2):390-8. DOI: 10.1016/s0008-6363(02)00785-x. View

20.

Tapscott S, Lassar A, Davis R, Weintraub H . 5-bromo-2'-deoxyuridine blocks myogenesis by extinguishing expression of MyoD1. Science. 1989; 245(4917):532-6. DOI: 10.1126/science.2547249. View